Aptevo Therapeutics Inc. (APVO) insider trading.
In Q3 2026, insiders at Aptevo Therapeutics Inc. reported 13 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 10
- Last filed
- 2026-08-10
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| White Marvin L | Director, Officer · Executive Chair | 3 | 0 | 0 |
| Huebner Dirk | Officer · SVP, CMO | 2 | 0 | 0 |
| Niederhuber John | Director | 1 | 0 | 0 |
| Kunz Barbara Lopez | Director | 1 | 0 | 0 |
| Abdun-Nabi Daniel | Director | 1 | 0 | 0 |
| Grant Grady III | Director | 1 | 0 | 0 |
| Kwon SoYoung | Officer · SVP, GC, BD & Corp Affairs | 1 | 0 | 0 |
| Taylor Daphne | Officer · SVP, CFO | 1 | 0 | 0 |
| Lamothe Jeffrey G. | Director, Officer · President and CEO | 1 | 0 | 0 |
| Harsanyi Zsolt | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Niederhuber John | M (A) | 400 | — | 400 | Form 4 |
| 2026-08-06 | Kunz Barbara Lopez | M (A) | 400 | — | 400 | Form 4 |
| 2026-08-06 | Abdun-Nabi Daniel | M (A) | 400 | — | 400 | Form 4 |
| 2026-08-06 | White Marvin L | F (D) | 406 | $4.07 | 1,261 | Form 4 |
| 2026-08-06 | White Marvin L | M (A) | 1,666 | — | 1,667 | Form 4 |
| 2026-08-06 | Grant Grady III | M (A) | 400 | — | 1,150 | Form 4 |
| 2026-08-06 | Huebner Dirk | F (D) | 156 | $4.07 | 482 | Form 4 |
| 2026-08-06 | Huebner Dirk | M (A) | 638 | — | 638 | Form 4 |
| 2026-08-06 | Kwon SoYoung | M (A) | 638 | — | 638 | Form 4 |
| 2026-08-06 | Taylor Daphne | M (A) | 638 | — | 638 | Form 4 |
| 2026-08-06 | Lamothe Jeffrey G. | M (A) | 961 | — | 961 | Form 4 |
| 2026-08-06 | Harsanyi Zsolt | M (A) | 400 | — | 400 | Form 4 |
| 2026-07-17 | White Marvin L | M (A) | 1 | — | 1 | Form 4 |
Transaction codes in this quarter
Get APVO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1671584&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · APVO company page · Aptevo Therapeutics Inc. on SEC.gov
Questions
Are insiders buying or selling Aptevo Therapeutics Inc. (APVO)?
In Q3 2026, insiders at Aptevo Therapeutics Inc. reported 13 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Aptevo Therapeutics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/apvo.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.